Complement Targets Newborn Retinal Ganglion Cells for Phagocytic Elimination by Microglia by Anderson, Sarah R. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Neurobiology Publications and Presentations Neurobiology 
2019-03-13 
Complement Targets Newborn Retinal Ganglion Cells for 
Phagocytic Elimination by Microglia 
Sarah R. Anderson 
University of Utah 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/neurobiology_pp 
 Part of the Developmental Neuroscience Commons, Embryonic Structures Commons, and the 
Nervous System Commons 
Repository Citation 
Anderson SR, Zhang J, Steele MR, Romero CO, Kautzman AG, Schafer DP, Vetter ML. (2019). Complement 
Targets Newborn Retinal Ganglion Cells for Phagocytic Elimination by Microglia. Neurobiology 
Publications and Presentations. https://doi.org/10.1523/JNEUROSCI.1854-18.2018. Retrieved from 
https://escholarship.umassmed.edu/neurobiology_pp/240 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Neurobiology 
Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please 
contact Lisa.Palmer@umassmed.edu. 
Development/Plasticity/Repair
Complement Targets Newborn Retinal Ganglion Cells for
Phagocytic Elimination by Microglia
Sarah R. Anderson,1,2 Jianmin Zhang,1Michael R. Steele,1 Cesar O. Romero,1 Amanda G. Kautzman,3
Dorothy P. Schafer,3 andMonica L. Vetter1
1Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, Utah 84112, 2Interdepartmental Program in Neuroscience, University of
Utah, Salt Lake City, Utah 84112, and 3Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts 01655
Microglia play important roles in shaping the developing CNS, and at early stages they have been proposed to regulate progenitor
proliferation, differentiation, and neuronal survival. However, these studies reveal contradictory outcomes, highlighting the complexity
of these cell– cell interactions. Here, we investigate microglia function during embryonic mouse retina development, where only micro-
glia, progenitors, and neurons are present. In both sexes, we determine that microglia primarily interact with retinal neurons and find
that depletion of microglia via conditional KO of the Csf1 receptor results in increased density of retinal ganglion cells (RGCs). Pharma-
cological inhibition of microglia also results in an increase in RGCs, with no effect on retinal progenitor proliferation, RGC genesis, or
apoptosis.We show thatmicroglia in the embryonic retina are enriched for phagocyticmarkers and observe engulfment of nonapoptotic
Brn3-labeled RGCs. We investigate the molecular pathways that can mediate cell engulfment by microglia and find selective downregu-
lation of complement pathway components with microglia inhibition, and further show that C1q protein marks a subset of RGCs in the
embryonic retina. KO of complement receptor 3 (CR3; Itgam), which is only expressed by microglia, results in increased RGC density,
similar to what we observed after depletion or inhibition ofmicroglia. Thus, our data suggest thatmicroglia regulate neuron elimination
in the embryonic mouse retina by complement-mediated phagocytosis of non-apoptotic newborn RGCs.
Key words: complement; microglia; phagocytosis; retina; retinal ganglion cell
Introduction
Microglia, the resident innate immune cells of the CNS, shape the
developing brain: from regulating the survival of neurons to re-
fining circuits (Nayak et al., 2014; Li and Barres, 2018).Microglia
derive from erythromyeloid precursors in the yolk sac and mi-
grate to the brain and retina at early embryonic stages (Ginhoux
et al., 2013). Microglia impact the generation and survival of
neurons in vitro, during development, and in adult neurogenic
zones (Ekdahl et al., 2009; Sato, 2015). However, microglia can
have varying effects on proliferation, differentiation, and neuro-
nal survival; and consequently, the mechanisms by which micro-
glia regulate neurogenesis in vivo are not fully understood.
Microglia maintain homeostasis by clearing dead or dying
cells as well as directly regulating death via secretion of cytokines
or reactive oxygen species (Bilimoria and Stevens, 2015). Fur-
thermore, growing evidence suggests that microglia can execute
stressed but viable cells by phagocytosis, a process called phagop-
tosis (Brown and Neher, 2014; Vilalta and Brown, 2018). While
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Significance Statement
Microglia are emerging as active and important participants in regulating neuron number in development, during adult neuro-
genesis, and following stemcell therapies.However, their role in these contexts and themechanisms involved arenot fully defined.
Using a well-characterized in vivo system, we provide evidence that microglia regulate neuronal elimination by complement-
mediated engulfment of nonapoptotic neurons. This work provides a significant advancement of the field by defining in vivo
molecular mechanisms for microglia-mediated cell elimination. Our data add to a growing body of evidence that microglia are
essential forpropernervous systemdevelopment. In addition,weelucidatemicroglia function in thedeveloping retina,whichmay
shed light on microglia involvement in the context of retinal injury and disease.
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phagoptosis has primarily been characterized in vitro, there is
evidence that microglia engulf viable neural progenitors in the
developing cortex (Cunningham et al., 2013) and nonapoptotic
neurons in contexts of injury or disease (Neher et al., 2013; Zhao
et al., 2015; Luo et al., 2016; Alawieh et al., 2018). Whether mi-
croglia regulate neuronal survival by phagoptosis in the develop-
ing CNS is unknown.
Multiple cell surface cues, or “eat-me signals,” stimulate mi-
croglial phagocytosis (Ravichandran, 2010; Fourgeaud et al.,
2016). The complement cascade is a highly conserved signaling
pathway important for innate immunity; allowing immune cells
to attack membranes or phagocytose invaders (Ricklin et al.,
2010). In the CNS, C1q, an initiation component of the comple-
ment pathway, tags neuronal synapses for microglial phagocyto-
sis both in development and disease, including pruning of retinal
ganglion cell (RGC) synapses for activity-dependent refinement
during postnatal periods (Stevens et al., 2007; Schafer et al., 2012;
Stephan et al., 2012; Hong et al., 2016). At present, the molecular
signals driving phagoptosis in vivo are largely undetermined, and
complement has not been implicated in the phagocytosis of en-
tire neurons in development.
In the retina, complex intrinsic and extrinsic processes regu-
late the production of sevenmajor groups of retinal cells (Bassett
and Wallace, 2012). Like other CNS regions, a substantial num-
ber of retinal neurons will be eliminated, a process presumed to
be driven by apoptosis (Francisco-Morcillo et al., 2014). RGCs
are the earliest-born retinal neurons and undergo the largest re-
duction in density (Perry et al., 1983; Farah, 2006), which is im-
portant for retinal function (Pe´quignot et al., 2003; Chen et al.,
2013). Shortly after birth, a large wave of RGC apoptotic death
occurs (Pe´quignot et al., 2003), but a less-studied, embryonic
wave of RGC loss has been observed in monkey, cat, chick, rat,
and mouse (Pe´quignot et al., 2003; Farah, 2006). However, it is
currently unclear what is driving this embryonic wave of RGC
loss because there isminimal apoptosis in themouseRGC layer at
this time.
The embryonic retina allows for unambiguous assessment of
microglial influence on neurogenesis and/or neuronal survival
because only microglia, retinal progenitors, and newborn neu-
rons are present.Here, we find thatmicroglia preferentially reside
adjacent and interact with neurons. By genetic depletion and
pharmacological inhibition of microglia, we demonstrate that
microglia normally limit RGC density and provide evidence that
this is via phagocytic elimination of nonapoptotic newborn cells.
We find that complement proteins are highly expressed in the
developing retina and are selectively regulated by inhibition of
microglia. Finally, loss of complement receptor 3 (CR3), which is
only expressed on microglia, results in increased RGC number.
Consequently, we provide evidence for a previously unknown
mechanism of RGC elimination and suggest a new role for com-
plement in the phagocytosis of entire, nonapoptotic neurons.
Materials andMethods
Animals and procedures.All animals were treated within the guidelines of
the University of Utah Institutional Animal Care and Use Committee,
and all experiments were Institutional Animal Care andUse Committee-
approved. C57B6/2J and B6.Csf1r floxed (021212) mice were purchased
from The Jackson Laboratory. The B6.CX3CR1gfp/ mice (Jung et al.,
2000) were a gift from Richard Lang with permission from Steffen Jung.
B6.Cx3cr1creERT2 mice (Yona et al., 2013) were a gift from Steffen Jung.
B6.RosaTdtomato mice (Madisen et al., 2010) were a gift from Mario
Capecchi. Postnatal CR3 KO and littermate control tissue was a gift from
Dorothy Schafer (Coxon et al., 1996). Mice were housed in an Associa-
tion for Assessment and Accreditation of Laboratory Animal Care-
accredited animal facility with 12 h light/12 h dark cycles and ad libitum
access to food and water. Timedmatings were used to determine embry-
onic stages, and both sexes were used for all experiments. The morning a
plug was detected was considered embryonic day 0.5. Minocycline (120
mg/kg) or the same volume of vehicle, 5% sucrose in PBS, was adminis-
tered once a day by oral gavage to pregnant dams from embryonic day (e)
12.5–15.5 or e12.5-e13.5. Tamoxifenwas administered to pregnant dams
by oral gavage on e9.5, e11.5, and e13.5 at 2, 3, and 3 mg, respectively; 45
g/g BW of 10 g/l stock BrdU was injected intraperitoneally 24 h
before death; 4 l/g BW of 5 mM stock 5-ethynyl-2-deoxyuridine (EdU)
was injected intraperitoneally 48 h before death. Animals of either sex
used for experiments were euthanized by isoflurane asphyxiation fol-
lowed by cervical dislocation.
Tissue processing. Following death, retinas were dissected in ice-cold
0.1 M PBS. Whole heads were fixed in 4% PFA for 45 min to an hour.
Heads were washed 3 times for 15 min in PBS and underwent 12–16 h
consecutive treatments with 15% and 30% sucrose in PBS at 4°C. Heads
were then embedded in OCT compound (Tissue-Tek), stored at80°C,
and sectioned at 16 m thickness. For retinal whole mounts, eyes were
removed from the head and retinas were carefully dissected from the rest
of the eye (cornea, lens, retinal pigment epithelium, hyaloid vasculature,
vitreous, ciliary body) in ice-cold PBS.Whole neural retinas were washed
in PBS for 10–20 min and then fixed in 4% PFA for 15–30 min at room
temperature with rocking.
Immunohistochemistry. Frozen sections were placed in ice-cold PBS
for 10 min, blocked for 1 h at room temperature (0.2% Triton-X, 10%
BSA, 10% normal donkey serum in 0.01 M PBS), then incubated in pri-
mary antibody overnight at 4°C in (0.2% Triton-X, 5% BSA in 0.01 M
PBS). The following day, sections were washed 3 with PBS and incu-
bated in secondary antibodies (5% BSA in PBS) for 2 h at room temper-
ature, washed, and mounted with Vectashield mounting medium with
DAPI (H-1200, Vector Laboratories). For whole-mount immunostain-
ing, retinas were incubated in primary antibody at 4°C for 3 d. An extra
incubation in 4 M HCl for 2 h and wash with a sodium borate buffer was
used for BrdU detection before primary antibody incubation. EdU was
detected per the Click-iT Plus Kit instructions (C10640, Thermo Fisher
Scientific). Primary antibodies used are as follows: goat Brn3 (1:50, Santa
Cruz Biotechnology sc-6026), rabbit phospho-histone H3 (pH3) (1:500,
Millipore 06-570), rabbit cleaved caspase-3 (CC3, 1:500, BD Biosciences
559565), mouse Rxr (1:250, Santa Cruz Biotechnology sc-365252),
mouse Brn3a (1:50, EMD Millipore MAB1585), rabbit calbindin (1:
2000, EMDMillipore PC253L), goat GFP (1:2000, Abcam ab5450), rab-
bit Iba1 (1:1000, Wako 019-19741), mouse BrdU (1:500, Thermo Fisher
Scientific B35128), mouse Cd68 (1:300,Bio-Rad MCA1957), rabbit C1q
(11500, Abcam ab182451), and rat Cd11b (1:50, BD Biosciences
563890). Secondary antibodies were produced in donkey against goat,
mouse, and rabbit IgG and conjugated to AlexaFluor-488, -555, -568, or
-647 (Thermo Fisher Scientific).
Confocal microscopy and image analysis. Confocal images were ac-
quired on an invertedNikonA1RConfocalMicroscope. For retinal cross
sections, 36 multipoint images were acquired (on average) at 20 objec-
tive with a 3 digital zoom to obtain a 0.2 m pixel resolution. Multi-
points were stitchedwith a 10%overlap. Stacks through theZ plane at 0.8
m steps spanning the entire thickness were max projected (16 m).
Images of retinal whole mounts were on average 144 multipoint images
of 30 m thickness. Image acquisition settings were consistent across
ages and genotypes. All analysis was performed manually and blinded
using Nikon Elements software. For microglia distribution, every fourth
section throughout the retina was analyzed. For all RGC counts (Brn3,
BrdU, and EdU), the dorsal central regions (300 m long,0.04 mm2)
of 5 or 6 central sections were analyzedmanually and averaged per retina.
Only one retina per animal was analyzed unless otherwise specified. RGC
densitywas calculated along 300mof central retina for P0-depleted and
CR3 WT/KO animals. Microglial density for P0 CR3 WT and KOs was
calculated by Iba1 counts of the central retina (300m long,0.05mm2
area). Microglia density and apoptosis analysis at e13.5 and e16.5 were
done on entire cross sections of 5 or 6 central sections per animal. For 3D
reconstruction of microglia-RGC interactions, IMARIS software (Bit-
plane) was used. In brief, high-resolution confocal images (20 objec-
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tive, 8 digital zoom) through Z (0.16 m steps) were uploaded into
IMARIS to create 3D renderings. N 5 animals were imaged.
Whole-retina qRT-PCR.After death, retinas were carefully dissected in
RNase-free conditions using ice-cold RNase-free PBS, removing all non-
neural eye tissue (ciliary body, pigmented epithelium, vitreous including
hyaloid vasculature at embryonic stages). Promptly, retinas were me-
chanically dissociated by careful trituration using a sterile 1 ml syringe
and 26-gauge needle in RLT buffer. Samples were frozen at80°C until
extraction. RNA was extracted using an RNeasy Micro Kit (QIAGEN,
74004). The concentration and purity of the RNA were measured by a
spectrophotometer (NanoDrop ND-1000). First strand cDNA synthesis
was performed using the SuperScript III First Strand cDNA synthesis kit
(Invitrogen,11752). Quantitative real-time PCR (qRT-PCR) was per-
formed using SYBR Select Master mix and run on the 7900 HT Fast
Real-Time PCR system with QuantStudio 12K Flex software (Applied
Biosystems) at the University of Utah Genomics Core. Relative quantifi-
cation was determined by Ct using the QuantStudio Software. Genes
of interest were normalized to  actin. Primers were designed using
Primer-BLAST software. Forward and reverse primer sequences in the 5
to 3 orientation are as follows:  actin, TGAGAGGGAAATCGTG
CGTG, TCGTTGCCAATAGTGATGACCTG; Iba1, CCTGATTGGA
GGTGGATGTCAC,GGCTCACGACTGTTTCTTTTTTCC;Cx3cr1, AA
AAACACTGGATTTCAGGGGC, CAACCAACACAGGAACAGGGAG;
Mertk, CGCTCTGGAGTGGAGGCAC, AAACGCAACAGGAGGTAG
GAG; Cd68, GGACACTTCGGGCCATGTTT, CTTACACAGTGGAC
TGGGGC; C1qb, ATGGATGCGTAATCACGGGG, GTCTGGGTTT
CAGGCAGTCAAG; C3, TCTGACCTCTGGGGAGAAAAGC, TGGG
ACAACCATAAACCACCATAG; Cd11b, TGTGGACTCTCATGCCT
CCT, TGGTCATCTCTGAAGCCGTG;Ccr2, GGAGCCATACCTGTAA
ATGCCA, GCCGTGGATGAACTGAGGTA; VNR, CGTCCTCCAG
GATGTTTCTCC, GCTTTGACCTCACAGAGGC; Mfge8, GTGACTTT
GGACACACAGCG,AGAACAACGGGAGGCTAGGT;Tyrobp,GGACC
CGGAAACAACACATTG, GATCCCAGAGAGGGCTTGTT; and LRP,
GTGTCCAACTGCACAGCAAG, GCAGACGTGAATGTCGCAAT.
Statistical methods. All data were analyzed using Prism 7 (GraphPad)
software. Unless stated, an unpaired two-tailed Student’s t test was per-
formed to determine statistical significance. If the two samples had un-
equal variances determined by an F test, we applied the Welch’s
correction. Two-way ANOVA was used to determine statistical signifi-
cance among groups with multiple independent variables (see Figs. 1E,
2F ) followed by a post hoc Sidak’s multiple-comparisons test. For qPCR
analyses, an unpaired Student’s t test was performed on the  Ct values.
Three litters of e20.5 depleted and P0CR3KOswere analyzed. Therefore,
Brn3 densities were normalized to littermate controls, and a one-sample
t test was performed to account for any potential age differences across
litters. Data are presented as themean; error bars indicate the SEM. qPCR
graphs represent fold change; error bars indicate the SEM of  Ct values.
We used a 95% CI. A p value of 	0.05 was set for rejecting the null
hypothesis.
Results
Microglia primarily associate with neurons in the
developing retina
Microglia are present as early as embryonic day (e) 11.5 in the
mouse retina, shortly after the onset of retinal neurogenesis,
shown by immunostaining of activation marker F4/80 (Santos et
al., 2008). To obtain a more detailed understanding of microglia
distribution during embryonic retinal neurogenesis, we per-
formed Iba1 immunostaining on cryosections from the Cx3cr1-
GFP knockinmouse line (Jung et al., 2000). CX3CR1 (fractalkine
receptor), and Iba1, a calcium binding protein, are expressed in
microglia and other leukocytes, including circulating monocytes
andmacrophages (Jung et al., 2000). Retinalmicroglia were iden-
tified as GFPIba1 cells within the retinal parenchyma, distin-
guishable from GFPIba1macrophage populations outside of
the retina, including vitreal macrophages (Fig. 1A, yellow arrow-
heads).We confirmed that these cells within the retina selectively
express themicroglia-specificmarker P2RY12 andnot themono-
cyte marker CCR2 (data not shown). At e12.5, e16.5, and post-
natal day (P0), Iba1 colocalized with GFP, but Iba1 levels were
more variable (Fig. 1A–C). The density of microglia appeared
highest at e12.5, consistent with previous work (Santos et al.,
2008), and was dynamic throughout development. Using whole-
retina qRT-PCR, we found that, relative to adult (P60), Cx3cr1
and Iba1 gene expression was highest at e12.5, decreased during
mid-embryonic stages, and increased again at P0, consistent with
the densities of microglia observed by immunostaining (Fig. 1D)
(n  3 each). The dramatic expansion of the retina during the
embryonic period results in reduced density of microglia, al-
though microglia numbers also continue to increase (data not
shown).
The embryonic retina consists of dividing progenitors and
neurons, both of which can be influenced by microglia in other
contexts (for review, see Li and Barres, 2018), so we sought to
determine with which cell populations microglia may be associ-
ating. Before e17.5, the retina can be divided into twomain layers:
the differentiated cell layer (DCL), consisting of newborn RGCs,
amacrine cells, and horizontal cells, and the neuroblastic layer
(NbL) comprised of mainly retinal progenitor cell bodies with
cones occupying the future photoreceptor layer along the apical
surface (outlined in Fig. 1B). Other newborn neurons, including
RGCs, begin to differentiate at the apical surface of the retina and
migrate through theNbL to theDCL. First, we analyzedmicroglia
density in the twomajor layers of the retina at e12.5 (n
 4), e14.5
(n
 4), and e16.5 (n
 6). Two-way ANOVA found a significant
difference across ages [F(2,22) 
 33.12, p 	 0.0001] and retinal
layers [F(2,22)
 122.3, p	 0.0001]. At every time point assessed,
microglial density was highest in the DCL by Sidak’s multiple-
comparisons test (Fig. 1E; e12.5, p 	 0.0001; e14.5, p 
 0.0122;
e16.5, p	 0.0001). We observed the majority of microglia in the
DCL directly contacting Brn3 RGCs. But due to the high den-
sity of RGCs, it was unclear whether this microglia-RGC contact
was simply due to chance. Therefore, we analyzed the percentage
of NbLmicroglia contacting migrating RGCs, where it was easier
to determine meaningful interactions (Fig. 1F,G; n
 4, 4, and 6
animals at e12.5, e14.5, and e16.5). Even though retinal progen-
itors vastly outnumber migrating RGCs in the NbL, almost 50%
of microglia in the NbL contacted migrating Brn3 RGCs at
e14.5, which persisted at e16.5 (Fig. 1G).
Microglia are important for the elimination of apoptotic cells
during development, and apoptosis facilitates microglia entry
and positioning in the zebrafish CNS (Casano et al., 2016; Xu et
al., 2016). Therefore, we also assessed the distribution and con-
tact of microglia to cleaved caspase-3-positive (CC3) cells.
Consistent with previous reports, overall apoptosis levels were
fairly low at the time points assessed. Of totalmicroglia present in
the retina, only 15% contacted CC3 cells at e12.5 and 7% at
e16.5 (Fig. 1H; n 
 4 e12.5; n 
 7 e16.5). Therefore, microglia
mainly reside in the DCL and primarily associate with neurons
during embryonic retinal neurogenesis.
Loss of colony stimulating factor 1 signaling conditionally
and selectively depletes retinal microglia
To determine their impact on neurogenesis, we designed a ge-
netic strategy to eliminate microglia. Colony stimulating factor 1
receptor (Csf1r) is essential for microglia survival in the brain
(Erblich et al., 2011;Nandi et al., 2012) aswell as the retina (Wanget al.,
2016), and pharmacological inhibition of CSF1R signaling results in
microglial death (Elmore et al., 2014). Because CSF1R is also ex-
pressed in neural progenitors (Nandi et al., 2012; Chitu et al., 2016),
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Figure 1. Microglial density is dynamic in the developing retina, and microglia primarily associate with newborn neurons. A–C, Representative confocal images of retinal cross sections and
central regions (A–C) at e12.5, e16.5, and P0: DAPI (blue), Iba1 (purple), Cx3cr1-gfp (green), and Brn3 (red). Dashed line indicates the boundary between the retina and vitreous where
Iba1GFP vitreal macrophages reside (yellow arrowheads). NbL and DCL outlined inB.D, qRT-PCR of whole-retina samples over embryonic development. Levels of Cx3cr1 and Iba1 expression
at various ages relative to P60 and normalized to actin (n 3 each). qPCR graph represents fold change relative to P60. Error bar indicates the SEM of Ct values. E, Microglial density in DCL and
NbL at e12.5, e14.5, and e16.5. [n
4, 4, and6 animals, respectively; two-wayANOVA: interaction, F(2,22)
9.265,p
0.0012; age, F(2,22)
33.12,p	0.0001; retinal layer, F(2,22)
33.12,p	
0.0001; Sidak’smultiple-comparisons: DCL vs NbL at e12.5, t(22)
 8.942, p	 0.0001; e14.5, t(22)
 3.206, p
 0.0122; e16.5, t(22)
 7.24, p	 0.0001; Sidak’smultiple-comparisons comparing
age: e12.5 vs e14.5, t(22)
 6.86, p	 0.0001; e12.5 vs e16.5, t(22)
 7.02, p	 0.0001; e14.5 vs e16.5, t(22)
 0.493, p
 0.948]. F, High-resolution confocal images with the Z plane of Iba1

microglia in the NbL in contact with amigrating Brn3 RGC (left) or not in contact (right). Iba1microglia (green) and Brn3 RGCs (red). Z plane shown to the right and bottom of images.White
cross represents point of interest. G, Percentage of Iba1 microglia in the NbL-contacting Brn3 RGCs at e12.5, e14.5, and e16.5 (n
 4, 4, and 6 animals, respectively). H, Percentage total
Iba1microglia contacting CC3 cells at e12.5 and e16.5 (n
 4 retinas, e12.5; n
 7 retinas, e16.5). Scale bars: 100m for whole-retina cross sections, 50m for high-magnification central
region, and 10m for microglia contact in NbL. Graphs represent the mean; error bars indicate SEM. Four or five sections per retina were analyzed. ****p	 0.0001. *p	 0.05.
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we developed a targeted strategy crossing mice expressing a
floxed Csf1r allele (Li et al., 2006) to the inducible Cx3cr1creERT2
mouse line (Yona et al., 2013) to conditionally disrupt the Csf1r
gene in the myeloid lineage (Fig. 2A). Tamoxifen was adminis-
tered to pregnant dams at e9.5, e11.5, and e13.5 by oral gavage
(Fig. 2B). To first test the specificity and efficiency of the system,
we used a Rosa-tdTomato reporter line to examine Cre activity
both in the absence of tamoxifen and following our three-dose
regimen (Cx3cr1creERT2 Rosa tdTomato) (Fig. 2C,D). In the ab-
sence of tamoxifen, very few Iba1 cells (1.58 0.54%) showed
Figure 2. Conditional loss of colony stimulating factor 1 receptor depletes embryonic retinal microglia. A, Genetic strategy for conditionally ablating microglia. B, Tamoxifen dosing regimen to
target embryonic retinal neurogenesis. Three doses of tamoxifen were administered by oral gavage to pregnant females every other day starting at e9.5 (2, 2, and 3 mg of 10 mg/ml tamoxifen in
corn oil). C, Quantification of tdTomatoIba1/Iba1 cells in whole-retina cross sections of Cx3cr1cre ERT2/ Rosa tdtomato/ Csf1r/ or fl/fl at e16.5 without tamoxifen and Cx3cr1cre ERT2/
Rosa tdtomato/ at e14.5 with tamoxifen (e16.5, n
 6; e14.5, n
 3; t(7)125.1, p	 0.0001). Individual dots represent means for each retina. D, Retinal cross sections of e16.5 Cx3cr1cre
ERT2/
Rosa tdtomato/ (top), Cx3cr1cre ERT2/ Rosa tdtomato/ Csf1r fl/ (middle), and Cx3cr1cre ERT2/ Rosa tdtomato/ Csf1r fl/fl (bottom) in the absence (top) and in the presence (middle, bottom) of
tamoxifen. D, Boxed regions at higher magnification. E, The 500 m2 box of retinal whole mounts of littermates, no Cre (Csf1r fl/fl) and Cre (Cx3cr1cre ERT2/ Csf1r fl/fl) at e16.5 exposed to
tamoxifen: Iba1microglia (black). F, Quantification of Iba1 density at e14.5 and e16.5 in Cre retinas and no Cre littermate controls (e14.5 no Cre n
 5, Cre n
 8; e16.5 no Cre n
 6, Cre n

6; two-way ANOVA: interaction, F(1,21)
 2.821, p
 0.1078; Cre expression, F(1,21)
 71.32, p	 0.0001; age F(1,21)
 2.565, p
 0.1242; Sidak’smultiple-comparisons test, e14.5 t(21)
 4.814,
p
 0.0006, e16.5 t(21)
 7.114, p	 0.0001).G, tdTomato
 density at e16.5 comparing Cx3cr1cre ERT2/ Csf1r fl/, and Cx3cr1cre ERT2/ Csf1r fl/fl (n
 3 Csf1r fl/, n
 5 Csf1r fl/fl; t(6)
 9.222,
p	 0.0001). H, Iba1 density at e20.5/P0 (n
 3 each; t(4)
 1.21, p
 0.293). Scale bars: 100m for retinal cross sections, 50m for whole mounts and higher magnification (C). Graphs
represent mean with SEM. Four or five retinal sections per retina were analyzed. ****p	 0.0001. ***p	 0.001.
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Cre activity by tdTomato expression at e16.5, suggesting negligi-
ble background activity (Fig. 2C,D, top; n 
 6). In contrast, at
e14.5, immediately following three doses of tamoxifen, 100% of
Iba1 cells were tdTomato (Fig. 2C; n 
 3; p 	 0.0001), con-
firming the efficacy of Cx3cr1creERT2 in retinal microglia.
Following tamoxifen administration to pregnant dams (Fig.
2B), retinas from Cx3cr1creERT2; Csf1r fl/fl (Cre) e16.5 embryos
displayed a substantial reduction in the number of Iba1 cells
compared with littermate controls exposed to tamoxifen and ho-
mozygous for the floxed allele but lacking Cre expression (no
Cre;Csf1r fl/fl) (Fig. 2D–F). Embryos heterozygous for the floxed
Csf1r allele (Cx3cr1cre ERT2; Csf1r fl/) had a slight reduction in
microglial density and therefore were not used as controls (Fig.
2D, middle). In Cx3cr1creERT2;Csf1r fl/fl retinas, we found a 70%
reduction in microglial density at e14.5 compared with no Cre;
Csf1r fl/fl retinas (n 
 5, no Cre; n 
 8, Cre; Sidak’s multiple-
comparisons, p
 0.0006; Cre, 25.98 7.06 Iba1/mm2; no Cre,
88.63 17.78 Iba1/mm2). At e16.5, microglial density was sim-
ilarly reduced in Cx3cr1creERT2;Csf1r fl/fl retinas (25.25  6.10
Iba1/mm2), despite the general increase in microglial density in
the control, no Cre;Csf1r fl/fl (119.01 4.88 Iba1/mm2) (Fig. 2F;
n 
 6, no Cre; n 
 6, Cre; Sidak’s multiple-comparisons, p 	
0.0001). Surviving microglia from Cx3cr1creERT2;Csf1r fl/fl reti-
nas, in general, had increased soma size and reduced branching
(Fig. 2E). To confirm that microglia were absent and not simply
downregulating Iba1, we assessed the number of tdTomato
cells in Cx3cr1creERT2; Rosa-tdTomato; Csf1r fl/fl retinas and
found a similar reduction in density, to 25.83 5.81 tdTomato/
mm2 [Figure 2G; n 
 3 controls (Cx3cr1creERT2; Rosa-
tdTomato; Csf1r fl/); n 
 5 Cx3cr1creERT2; Rosa-tdTomato;
Csf1r fl/fl; p 	 0.0001]. Microglial density returned to WT levels
e20.5/P0 (Fig. 2H; n 
 3 each; p 
 0.293), consistent with
reports of microglia repopulation after depletion in the adult
CNS (Elmore et al., 2014; Huang et al., 2018a,b).
There was significant tdTomato expression outside of the
retina as CX3CR1 is expressed in other myeloid cells in the eye,
including in vitreal macrophages. However, Cx3cr1microglia
within the retina were selectively vulnerable to Csf1r loss, con-
gruous with published work (Elmore et al., 2014, 2015; Hilla et
al., 2017). Vitreal macrophages were indeed increased in
Cx3cr1cre ERT2;Csf1r fl/fl retinas compared with littermate
controls (data not shown; n 
 3 each; two-tailed Student’s
t test, p 
 0.0006). Therefore, retinas from Cx3cr1creERT2;
Csf1r fl/fl animals (referred to as “depleted” hereafter) show a sig-
nificant and profound loss of microglia following tamoxifen
exposure, without depletion of surrounding macrophage popu-
lations during a specific time window and without disrupting
Csf1r signaling in progenitors. This genetic strategy allows tar-
geted assessment of microglia function during embryonic retinal
neurogenesis.
Figure 3. Loss ofmicroglia increases RGC density. A, Representativewhole-retina cross sections of e14.5 control and depleted retinas illustrating area of analysis (A): Brn3 RGCs (red), Iba1
microglia (green), and tdTomato (purple). B, Quantification of dorsal central Brn3 RGC density in controls and depleted at e14.5 (n
 5 control, n
 8 depleted; t(11)
 6.025, p	 0.0001).
C, Representative whole-retina cross sections and dorsal central regions (C) of e16.5 control and depleted retinas: Brn3 RGCs (red), Iba1 microglia (green), and tdTomato (purple).
D, Quantification of dorsal central Brn3 RGC density in control and depleted retinas at e16.5 (n
 3 each; t(4)
 3.074, p
 0.0372). Scale bars: 100m for whole retinas (A, C) and 50m for
higher magnification (A, C). Graphs represent mean with SEM. Individual dots represent means for each retina. ****p	 0.0001. *p	 0.05.
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Microglia regulate RGC density in the
embryonic retina
Because microglia closely associate with
newborn neurons, we asked whether mi-
croglia influence their numbers. We ini-
tially focused on RGCs because they are
the first-born and most abundant neuron
of the retina at early embryonic stages.
Mouse RGC genesis initiates at e10.5 and
concludes around birth, with peak pro-
duction at e13.5-e14.5 (Sidman, 1961;
Young, 1984). We performed immuno-
staining for Brn3 on cryosections of de-
pleted and control embryos at e14.5 and
e16.5 and analyzed the density of Brn3
RGCs in a fixed area of the retina, the dor-
sal central region. Compared with litter-
mate controls, depleted retinas had
increased RGC density during peak RGC
generation at e14.5 (control, 6880 
94.03; depleted, 8045  139.4 Brn3/
mm2) (Fig. 3A,B; n 
 5 control; n 
 8
depleted; p
 8.6E-05) aswell as 48 h later,
at e16.5 (control, 6666 120.5; depleted,
7393  203.6 Brn3/mm2) (Fig. 3C,D;
n 
 3 each; p 
 0.037). Therefore, these
data suggest that microglia normally re-
strict RGCnumber during embryonic ret-
inal development.
To confirm our findings thatmicroglia
were regulating RGC density, we used
pharmacological inhibition of microglia
to selectively perturb microglial function.
Minocycline, a tetracycline derivative, is
commonly used to suppressmicroglial ac-
tivity during development (Schafer et al.,
2012; Cunninghamet al., 2013; Kobayashi
et al., 2013; Ueno et al., 2013; Shigemoto-
Mogami et al., 2014). Minocycline or ve-
hicle alonewas administered once a day to
pregnant dams from e12.5 to e15.5 by oral
gavage (Fig. 4A). First, we confirmed mi-
croglial inhibition by whole-retina qRT-
PCR. Cx3cr1, which is not altered with
microglial activation, was not signifi-
Figure 4. Pharmacological inhibition of microglia increases RGC density with no change in other early born cell types.
A,Minocyclinedosing regimen targetingembryonic retinal neurogenesis. The120mg/kgofminocyclineor vehicle alonewasgiven
by oral gavage once daily for 4 d beginning at e12.5.B, Whole-retina qRT-PCR at e16.5 analyzingmicroglia transcripts Cx3cr1 and
Iba1 (n
 3 control, n
 10minocycline-treated; Cx3cr1 t(11)
 0.9771, p
 0.350; Iba1 t(11)
 4.127, p
 0.0017), normalized
to actin and fold change relative to vehicle only controls. qPCR graph represents fold change. Error bars indicate the SEM of Ct
values. C, Quantification of GFP cells in control and minocycline-treated retinal cross sections (n
 9 animals each; t(16)

0.4183 p
 0.681 with Welch’s correction). D, Representative retinal cross sections at e16.5 of control and minocycline-treated
retinas: DAPI (blue) and Cx3cr1-gfp (green). C, Higher-magnification images of dorsal central region. E, High-magnification view
of individual GFP microglia from retinal whole mounts. F, Representative retinal cross sections of control and minocycline-
treated animals at e16.5with higher-magnification analyzed dorsal central region of RGCs. Higher-magnification viewbelow (F):
Brn3 RGCs (red) and GFP microglia (green). G, Quantification of dorsal central Brn3 RGC density in control and
4
minocycline-treated retinas at e16.5 (n 
 6 animals each;
t(10)
2.53,p
0.0299). Individual dots representmeans for
each retina. H, Representative images of dorsal central region
analyzing horizontal and amacrine cells: Brn3a RGCs (red)
and calbindin (green). I, Quantification of calbindin
Brn3a cells at e16.5 of control and minocycline-treated ret-
inas (n
 6 control, n
 5 treated; t(9)
 0.318, p
 0.758).
J, Representative images of dorsal central region Rxr cells
along the apical surface. Rxr (teal). K, Quantification of
RxrBrn3 cell density along 300mof the apical surface
at e16.5 of control and minocycline-treated retinas (n 
 4
control, n
 4 treated; t(6)
 1.394, p
 0.213). Scale bars:
100m for whole-retina cross sections (D, F) and 50m for
higher-magnification central regions in (D, F, H, J), 10m
for individual microglia (E). Graphs represent mean SEM.
***p	 0.001. *p	 0.05.
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cantly changed, whereas Iba1mRNA was reduced nearly 60% in
minocycline-treated retinas compared with vehicle-only controls,
suggesting efficient microglial inhibition (Bosco et al., 2008; Ko-
bayashi et al., 2013) (Fig. 4B; n
 3 control; n
 10 minocycline;
Iba1 p
 2.2E-05; Cx3cr1 p
 0.159). Overall, microglial density,
distribution, and morphology were unaffected following mino-
cycline treatment (Fig. 4C–E; n
 9 each; p
 0.686).
Analogous to depletion experiments, we observed a signifi-
cant increase in RGCdensity inminocycline-treated retinas com-
pared with controls (Fig. 4F,G; n 
 6 each; p 
 0.0299). To
determine whether other early born cell types were affected, we
assessed calbindin Brn3a amacrine and horizontal cells and
found no significant difference with treatment (Fig. 4H, I; n
 6
control; 5 minocycline; p 
 0.758). We also examined control
and minocycline-treated retinas at P6 after amacrine cell gen-
esis is complete and observed no consistent change in calbin-
din  amacrine cell density (data not shown). Similarly, cone
(RxrBrn3) density was unchanged with minocycline treat-
Figure 5. Perturbation of microglia does not change retinal progenitor proliferation or RGC genesis. A, Retinal cross sections of control and minocycline-treated retinas at e16.5 with higher
magnified analyzed dorsal central region (A) of pH3 (red).B, Density of pH3 along 300m length of apical surface of dorsal central region of control andminocycline retinas (n
 6 animals each;
t(10)
 0.978, p
 0.351). C, Dosing regimen for tamoxifen (e9.5, e11.5, e13.5), EdU (e12.5), and BrdU (e13.5) injections.D, Representative retinal cross sections of control andmicroglia depleted
animals at e14.5 injected with EdU at e12.5 and BrdU at e13.5, with higher magnified analyzed dorsal central region (D): DAPI (blue), Brn3 RGCs (green), BrdU (red), and EdU (purple). Yellow
arrowheads indicate RGCs born between e13.5 and e14.5 (BrdU EdU/ Brn3). White arrowheads indicate RGCs born between e12.5 and e13.5 (EdU BrdU Brn3). E, Quantification of
RGCs born between e13.5 and e14.5 (BrdU EdU/ Brn3) in control and depleted retinas (n
 8 animals/13 retinas controls, n
 7 animals/10 retinas depleted; t(21)
 0.190, p
 0.8511).
F, Quantification of RGCs born between e12.5 and e13.5 (EdU BrdU Brn3) in control and depleted retinas (n
 5 animals/10 retinas controls, n
 3 animals/6 retinas depleted; t(14)
 2.45,
p
 0.0279). Scale bars: 100m for whole-retina cross sections (A, D) and 50m central regions (A, D). Graphs represent mean with SEM. *p	 0.05.
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ment (Fig. 4J; n
 4 each; p
 0.213). Overall, these data confirm
our results from depletion experiments and further suggest that
microglial function, modulated by minocycline, is required to
regulate RGC density.
Perturbation of microglia does not change retinal progenitor
proliferation, RGC genesis, or RGC apoptosis
To determine whether more RGCs were produced, we first as-
sessed progenitor proliferation in minocycline-treated and con-
trol retinas. We reasoned that, if microglial perturbation was
increasing differentiation of RGCs, normally mitotic progenitors
might exit the cell cycle and, consequently, be diminished in
minocycline-treated retinas. However, we did not observe a
change in actively cycling progenitors in the G2 to M transition
(pH3) following minocycline treatment at e16.5 (Fig. 5A,B;
n
 6 each; p
 0.351).
To test whether there was an increase in RGC genesis follow-
ing microglia perturbation, we labeled RGCs with BrdU during a
specific time window in depleted and control retinas. BrdU was
administered to pregnant females at e13.5 and euthanized 24 h
later, whenRGCdensity was already increased in depleted retinas
(Fig. 5C). There was no significant difference in RGCs born
within this 24 h time window (BrdUBrn3) in depleted versus
control animals (Fig. 5D,E; n 
 8 animals/13 retinas controls;
n 
 7 animals/10 retinas depleted; p 
 0.851), suggesting that
microglia are not regulating RGC differentiation. We next per-
formed a longer pulse to determine whether, instead, newly gen-
erated RGCs were persisting in depleted retinas relative to
controls. EdU was administered at e12.5, BrdU at e13.5, and an-
imals were euthanized at e14.5 (Fig. 5C). Thus, RGCs born be-
tween e12.5 and e13.5 were EdU and BrdU. Compared with
littermate controls, RGCs born between e12.5 and e13.5 were
significantly increased in depleted retinas at e14.5 (Fig. 5D,F; n

5 animals/10 retinas controls; n 
 3 animals/6 retinas depleted;
p 
 0.0279). Therefore, these results suggest that microglia are
not influencing RGC differentiation but instead regulating the
survival of newborn RGCs 24–48 h after their birth.
To test whether microglia normally restrict RGC survival, we
first analyzed apoptosis in minocycline-treated retinas and con-
trols by CC3 immunostaining. If microglia were normally pro-
moting apoptosis, we would expect to see a decrease in total
number of CC3 cells with microglial inhibition, or an increase
in CC3 cells if microglia were simply clearing dying RGCs.
However, at e16.5, there was no significant change in the total
number of CC3 cells in minocycline-treated retinas compared
with controls (Fig. 6A,B; n
 6 each; p
 0.731) and no decrease
specifically in the DCL (Fig. 6B). Further, we did not observe a
change in the number of CC3 contacted by microglia (Fig. 6C;
n 
 7 each; p 
 0.717) or a significant difference in the average
distance of microglia to CC3 cells following treatment (Fig. 6D;
n 
 7 each; p 
 0.268). Therefore, minocycline treatment does
not change overall apoptosis levels or inhibit microglial migra-
tion or contact with CC3 cells. To assess whether apoptosis
could be altered during the time window in which we saw an
increase in RGCs by birth-dating analysis (Fig. 5D,F), we gave
animals a dose ofminocycline at e12.5 and e13.5 and analyzed 2 h
later. However, there was still no significant change in the num-
ber of apoptotic cells (Fig. 6E; n
 3 each; p
 0.645). Together,
our data suggest that microglia normally limit the number of
RGCs, but not by inducing CC3-dependent apoptosis or by pas-
sive clearance of apoptotic RGCs.
Microglia interact with non-CC3 RGCs at embryonic stages
Because there was no change in activated CC3 expression in
minocycline-treated animals and no change in RGC genesis, we
hypothesized that microglia might eliminate non-CC3 RGCs.
Consistent with this hypothesis, we observed many phagocytosis
events at e12.5 and e13.5 in retinal whole mounts by confocal
Figure 6. Inhibition ofmicroglia does not change retinal cell apoptosis or alter microglial contact with apoptotic cells. A, Representative retinal cross sections of control andminocycline-treated
animals at e16.5 with higher magnification (C): DAPI (blue) and CC3 apoptotic cells (white). B, CC3 cells at e16.5 of control and minocycline-treated retinas [n
 6 animals each; two-way
ANOVA: interaction, F(1,20)
 0.039, p
 0.846; treatment, F(1,20)
 0.597, p
 0.449; retinal layer, F(1,20)
 0.9473, p
 0.342; Sidak’smultiple-comparisons:minocycline vs control DCL, t(20)

0.685, p
 0.7511; NbL, t(20)
 0.407, p
 0.903]. C, Number of CC3
 cells at e16.5 contacted bymicroglia (n
 7 each; t(12)
 0.3712, p
 0.717). D, Average distance of microglia to a CC3

cell. Each dot represents the mean distance for a particular retina (n
 7 each; t(12)
 1.162, p
 0.268). E, CC3
 cells at e13.5 of control and minocycline-treated retinas (n
 3 animals each;
t(4)
 0.498, p
 0.645). Scale bars: 100m for whole-retina cross sections (A) and 50mhigher-magnification central regions (A). Graphs indicate mean with SEM. Individual dots represent
individual retinas.
Anderson et al. • Complement Mediates Phagocytosis of Newborn Neurons J. Neurosci., March 13, 2019 • 39(11):2025–2040 • 2033
microscopy and IMARIS-based 3D rendering (Fig. 7A–I). While
CC3 cells were rare, we did observe microglia engulfing CC3
apoptotic cells that were almost always Brn3 (Fig. 7A,E). More
abundantly, however, we found microglia contacting and inter-
acting with Brn3 RGCs (Fig. 7B–D,F–I). Analysis through the
Z plane verified microglia ensheathing RGCs and entire Brn3
cells within microglia (Fig. 7B). Additionally, costaining with
CC3 revealed that these RGCs were not undergoing CC3-
mediated apoptosis (Fig. 7C,D,F,G; Movies 3, 4, 5). Microglia
formed phagocytic cups (Fig. 7C,F; Movie 4) and also ensheathed
entire Brn3 RGCs (Fig. 7B,D,G–I; Movies 1, 2, 3). We also ob-
servedwhat appeared to be Brn3-labeled fragments insidemicroglia
(Movie 5).Manyof these eventswere occurring right at the interface
of the DCL and NbL, suggesting that newly born RGCs were being
targeted, consistent with our BrdU analysis (Fig. 5F).
To further test whether microglia regulate RGC number by
engulfment, we assessed microglia gene expression patterns by
whole-retina qRT-PCR.We analyzed genes at e12.5 relative to P0,
the end of embryonic development when microglia density is
comparable and RGC generation is largely complete. We ana-
lyzed genes associated with phagocytosis: recognition receptor
Tyrosine-protein kinase Mer (Mertk), lysosomal protein Cd68,
complement component 1q (C1qb), and complement compo-
nent 3 (C3). Relative to P0, all genes were highly upregulated at
e12.5 (Fig. 7J; n
 3 each; Mertk, p
 4.8E-05; Cd68, p
 0.0031;
C1qb, p
 0.0012; C3, p
 0.0018).We confirmed that these gene
expression patterns were not due to contamination from periph-
eralmacrophages because we could not amplify themacrophage-
specific gene,Ccr2, by qPCR at any age (data not shown).Wenext
asked whether the subset of RGCs being eliminated were viable.We
depletedmicroglia asbefore (Fig. 2) andagedanimalsuntil e20.5/P0.
If the normally eliminated RGCs were viable, we would predict a
sustained increase in RGC density at birth. Consistent with this,
Brn3 RGC density was increased compared with littermate con-
trols at e20.5/P0 by 20% (Fig. 7K; n 
 3 animals/5 retinas; one-
sample two-tailed t test p 
 0.0023). These data suggest that
microglia are contacting and eliminating viable RGCs.
Figure 7. Microglia are phagocytic at embryonic stages and interact with RGCs. A, High-resolution confocal image of microglial engulfment of an apoptotic cell (CC3): DAPI (blue),
Cx3cr1-gfpmicroglia (green), Brn3 RGCs (red), and CC3 (white). B, Microglia engulfing Brn3 RGC. Right, bottom, Z planes: Cx3cr1-gfpmicroglia (green) and Brn3 RGCs (red). C, D,
Microglia interacting with non-CC3 RGCs: DAPI (blue), Cx3cr1-gfpmicroglia (green), Brn3 RGCs (red), and CC3 (white). E–I, IMARIS-based 3D reconstruction of microglia interacting with
RGCs: Cx3cr1-gfpmicroglia (green), Brn3 RGCs (red), and CC3 (white). F, Reconstruction of C.G, Reconstruction ofD. J, Genes associatedwith phagocytosis assessed at e12.5 relative to P0 by
whole-retinaqRT-PCR.Normalized toactin (n
3each;Mertk, t(4)
18.74,p	0.0001; Cd68, t(4)
6.71,p
0.0026; t(4)
16.41; C1qb,p	0.0001; C3, t(4)
7.33,p
0.0018). qPCRgraph
represents fold change. Error bar indicates the SEM of  Ct values. K, Percentage of Brn3
 RGC density in depleted retinas normalized to littermate control retinas at e20.5/P0 (n
 5 retinas/3
animals each; one-sample t test, t(4) 
 6.898, p 
 0.0023). Scale bars: E, F, 10 m; G, 3 m; H, I, 5 m. Unpaired Student’s t test was used to determine significance of  Ct values.
****p	 0.0001. **p	 0.01. Movie 4 is of C, F. Movie 3 is of D, G. Movie 1 is of H. Movie 2 is of I.
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Complement proteins and phagocytosis are reduced
following minocycline, and CR3/Cd11b KO retinas have
increased RGC density
Minocycline has previously been implicated in reducing phago-
cytic activity (Schafer et al., 2012). Therefore, we proposed that
readouts of phagocytosis would be diminished in minocycline-
treated retinas. We first assessed the lysosomal-associated pro-
tein, Cd68, in retinal cross sections of animals given two doses of
minocycline or vehicle only once a day at e12.5 and e13.5 and
analyzed 2 h later (Fig. 8A).While there was no significant reduc-
tion in total density of GFP microglia in treated retinas, the
density of microglia with visible lysosomal compartments
(GFPCD68) was significantly reduced compared with con-
trols (Fig. 8B; n 
 3 each; p 
 0.044). We then assessed gene
expression of candidate phagocytosis genes in e13.5 minocycline
and control retinas. We confirmed efficacy of minocycline treat-
ment by a 38% reduction in Iba1 mRNA (Fig. 8C; n 
 8 con-
trols; n 
 12 minocycline-treated; p 
 0.0046). However,
common recognition receptors and associated phagocytosis
genes were largely unchanged (Fig. 8C). Mertk, Milk fat globule
Movie 1. IMARIS 3D rendering of a microglia cell wrapping around
an entire RGC in Figure 7H. Green represents Cx3cr1-gfp. Red represents
Brn3.
Movie 2. IMARIS 3D rendering of amicroglia cell engulfing an entire
RGC in Figure 7I. Green represents Cx3cr1-gfp. Red represents Brn3.
Movie 3. IMARIS 3D rendering of amicroglia cell ensheathing a non-
CC3 RGC in Figure 7D, G. Green represents Cx3cr1-gfp. White repre-
sents CC3. Red represents Brn3.
Movie 4. IMARIS 3D rendering of amicroglial phagocytic cup around
a non-CC3 RGC in Figure 7C, F. Green represents Cx3cr1-gfp. White
represents CC3. Red represents Brn3.
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epidermal growth factor 8 (Mfge8), and Itgav of the vitronectin
receptor (VNR), which recognize exposed phosphatidylserine,
were not significantly altered following minocycline treatment
(n
 8 controls; n
 12 minocycline-treated; MertK, p
 0.732;
Mfge8, p 
 0.516; VNR, p 
 0.144). Tyrobp, which encodes
DAP12, a coreceptor previously implicated in the recognition of
dying cells (Wakselman et al., 2008), was not significantly down-
regulated following minocycline treatment (p 
 0.197). How-
ever, Lipoprotein receptor-related protein 1 (Lrp1), which can
recognizeC1q and exposedCalreticulin on stressed or dying cells,
was significantly downregulated with treatment (p 
 0.013)
(Brown and Neher, 2014). Because complement proteins were
highly upregulated at e12.5 (Fig. 7J), we measured expression of
Cd11b, a subunit of the CR3 as well as C3 and C1q. Minocycline
treatment significantly reduced expression of both Itgam
(Cd11b) andC3 but notC1qb at e13.5 (Fig. 8D; n
 8 controls; 12
minocycline; Itgam p
 0.008; C3, p
 0.011; C1qb, p
 0.314);
however, at e16.5, we also saw a significant reduction in C1qb
expression (Fig. 8D; n 
 3 control; n 
 10 minocycline; p 

0.00047). We also analyzed expression of Mertk, VNR, Mfge8,
Gas6, Calreticulin, and “don’t eat me” signal Cd47 at e16.5 and
found that, again, nonewas altered (data not shown). Thus, of the
known recognition receptors and accessory proteins known to be
important for microglia phagocytosis, complement components
were selectively downregulated with minocycline treatment.
To determinewhether complementmay bemarkingRGCs for
phagocytic elimination, we assessed protein localization of C1q
by immunostaining.We found that microglia highly express C1q
as expected, but also observed Brn3 RGCs were colabeled with
C1q in whole-mount retinas at e13.5 (Brn3 C1q GFP) (Fig.
8E). Furthermore, we observed contact between GFPC1qmi-
croglia and C1q Brn3 RGCs (Fig. 8E1,F). We did find that
C1q expression only localized to a subset of RGCs (Fig. 8E2,E3).
This was confirmed in retinal cross sections at e16.5, which again
showed that a subset of Brn3 RGCs were C1q (Fig. 8F). We
predominately saw C1q Brn3 RGCs along the edge of the
DCL, consistent with our hypothesis that microglia target newly
born RGCs. At P0, C1q was deposited in the emerging inner
plexiform and nerve fiber layers, but we did not observe C1q
Brn3 RGCs, suggesting that RGCs are marked during a narrow
developmental window (data not shown). While both microglia
and RGCs can produce C1q (Stevens et al., 2007; Fonseca et al.,
2017), only microglia express complement receptor 3 (CR3,
Cd11b) within the CNS (Jeong et al., 2013). Because Cd11b tran-
script was diminished (Itgam; Fig. 8D), we next tested whether
Cd11b protein was also reduced following minocycline treat-
ment. In retinal cross sections at e13.5, we observed a significant
reduction in the density of CD11bHi microglia in minocycline-
treated retinas compared with controls similar to previous work
(Schafer et al., 2012) (Fig. 8G,H; n
 3 each; p	 0.02).
We next directly tested whether complement signaling
throughCR3was required for regulation of RGCnumber. There-
fore, we analyzed RGC density in CR3 KOs, with the prediction
that RGCs would be increased in the absence of the recognition
receptor. Compared with WT littermate controls (CR3 WT), we
found P0 CR3 KOs had significantly more Brn3 cells per
millimeter (Fig. 8 I,K; n 
 5 animals/10 retinas WT and n 
 5
animals/9 retinas KO; normalized to controls, one-sample two-
tailed t test, p 
 0.006) with no change in microglial density by
Iba1 immunofluorescence (Fig. 8 I, J; n 
 5 animals/10 retinas
WT and n
 5 animals/9 retinas KO; two sample two-tailed t test,
p 
 0.122). Together, these results suggest that microglia use
complement signaling to recognize and eliminate a subset of
non-CC3, newborn RGCs.
Discussion
The proper development of the CNS, including the retina, re-
quires the appropriate balance of neuron production and elimi-
nation to attain the correct number of cell types (Oppenheim,
1991). It is estimated that half of the original cell population in
the developing CNS is eventually eliminated (Oppenheim, 1981;
Burek and Oppenheim, 1999). Therefore, signals facilitating the
delicate balance between cell survival and cell death are indis-
pensable for maintaining tissue homeostasis. The most studied
cell elimination processes during development commonly in-
volve apoptotic programs (Jacobson et al., 1997; Yamaguchi and
Miura, 2015). Generally, initiation of a cascade of proapoptotic
events occurs in one of two ways: self-execution driven by intrin-
sic programs or extrinsic signals, such as death ligands (Johnson
andDeckwerth, 1993).However, there is increasing evidence that
there are non–cell-autonomousways to regulate neuron number
that do not require apoptosis.
During retinal development, 50% of RGCs produced will
undergo developmental death during the first postnatal week
(Farah, 2006). Postnatal RGC loss requires apoptosis and is hy-
pothesized to be a result of overproduction of RGCs competing
for limited neurotrophic supply and by activity-dependent pro-
cesses (Perry et al., 1983; Oppenheim, 1991; Pe´quignot et al.,
2003; Farah, 2006). However, most investigations of RGC devel-
opmental death neglect prenatal periods, likely because little ap-
optosis, identified by CC3 and TUNEL, is detected in the DCL
prenatally (Young, 1984) and ongoing RGC genesis makes anal-
ysis complex. Direct counts of RGC axons in other mammals
reveals an embryonic wave of RGC loss (Crespo et al., 1985; Wil-
liams et al., 1986), and analysis of RGC somas at individual time
points in mouse (Farah and Easter, 2005) predicts a 10%–15%
loss of RGCs before birth. Here, we find that this embryonic wave
Movie 5. IMARIS 3D rendering of Brn3 protein fragments inside a
microglial cell not colocalized with CC3. Green represents Cx3cr1-gfp.
White represents CC3. Red represents Brn3.
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Figure 8. Complement proteins are downregulated with minocycline treatment, and loss of CR3/Cd11b results in increased RGC density. A, Minocycline dosing regimen at e12.5 and e13.5 and
death 2 h later. B, Quantification of overall microglial density (GFP/mm2) and the density of microglia with Cd68 lysosomal compartments (Cd68GFP/mm2) in minocycline-treated and
control retinas at e13.5 (n
3each; control, 159.27.81;minocycline, 132.96.66GFP/mm2; t(4)
2.56,p
0.063; control, 118.112.7;minocycline, 59.8215.43Cd68
GFP/mm2;
t(4)
 2.913, p
 0.044). C, Whole-retina qRT-PCR of Iba1 and microglial receptors commonly associated with phagocytosis (n 6 control, n 11 minocycline; Iba1, t(18)
 3.23, p
 0.0046;
Mertk, t(18)
 0.348, p
 0.732; VNR, t(18)
 1.53, p
 0.144;Mfge8, t(10)
 0.673, p
 0.516; Tyrobp, t(17)
 1.34, p
 0.197; LRP, t(17)
 2.77, p
 0.013). Normalized to actin and relative
to age-matched vehicle only controls.D,Whole-retina qRT-PCR of complement proteins (n 6 controls, n 11minocycline-treated; Cd11b, t(18)
 2.96, p
 0.008; C3, t(16)
 1.912, p
 0.074;
e13.5, C1qb, t(18)
 1.04, p
 0.314; e16.5, C1qb, n
 3 controls, 10 treated; t(11)
 4.91, p
 0.0005). Normalized to actin and relative to age-matched vehicle only controls. E, e13.5 retinal
wholemounts of Cx3cr1-gfp (green), Brn3 (red), C1q (white), andmerge. Insets, C1q RGC contacted bymicroglia (1), C1q RGC (2), and C1q RGC (3). Yellow arrowheads indicate C1q RGCs.
F, e16.5 retinal cross sections of Cx3cr1-gfp (green), Brn3 (red), C1q (white), and merge. Inset, Magnification of C1q RGCs along DCL border. Yellow arrowheads indicate C1q RGCs. G, e13.5
retinal cross sections of Cd11b immunostaining: DAPI (blue), Cx3cr1-gfp (green), and Cd11b (red). Yellow arrowheads indicate Cd11b HI microglia.White arrowheads indicate Cd11b Lomicroglia.
H, Quantification of microglia highly expressing Cd11b (GFP Cd11b Hi) at e13.5 (n
 3 each; control, 86.73 3.71, minocycline, 55.45 7.48; t(4)
 3.75, p
 0.02). I, Retinal cross sections of
e16.5 control (CR3WT) and complement receptor (CR3) KOanimals: Iba1 (green) andBrn3 (red). J, Analysis ofmicroglial density (Iba1/mm2) in CR3KOand littermateWT controls (n
5animals/10
retinas WT, 127.4 5.42; n
 5 animals/9 retinas KO, 140.3 5.74; two-sample t test t(17)
 1.626, p
 0.122). K, Analysis of RGC density in CR3 KO and controls. Data were normalized to
littermate controls because 3 litters were used (n
 5 animals/10 retinas WT, n
 5 animals/9 retinas KO; one-sample t test t(8)
 3.71, p
 0.006). Scale bars: 50m for retinal whole mounts
and central regions of retinal cross sections, 10m for higher-magnification insets, and in G. C, D, qPCR graphs represent fold change. Error bar indicates the SEM of  Ct values. Graphs represent
mean h SEM. ***p	 0.001. **p	 0.01. *p	 0.05.
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of RGC loss requires microglial presence and function with no
change in caspase-dependent apoptosis programs.
Microglia can eliminate neurons in a matter of hours (Neher
et al., 2011; Zhao et al., 2015), making phagocytic events hard to
detect at static time points ex vivo. Nevertheless, increasing evi-
dence suggests that phagocytosis is a highly regulated, complex
process with functions beyond passive clearance of dying cells or
cellular debris. The active elimination of stressed, but viable, cells
has been dubbed phagoptosis, or primary phagocytosis, and
events are well documented in culture (Brown and Neher, 2012,
2014; Vilalta and Brown, 2018). There is also evidence in vivo
both during development and disease that microglia can elimi-
nate nonapoptotic cells. During cortical development, microglia
engulf viable neural progenitors to limit the number of neurons
generated (Cunningham et al., 2013). Microglia contribute to
retinal degeneration by the phagocytosis of living but stressed
photoreceptors in Rd10 mutants (Zhao et al., 2015). Addition-
ally, microglia phagocytose viable neurons during transient cere-
bral ischemia (Neher et al., 2013; Alawieh et al., 2018) and adult
newborn dentate granule cells in amousemodel of temporal lobe
epilepsy (Luo et al., 2016). We provide evidence that microglia
also actively select a subpopulation of seemingly viable RGCs to
be eliminated in the developing retina. It remains possible that
microglia secrete factors to stimulate non–CC3-dependent
death. However, we find microglial phagocytosis is high during
relevant time periods, is regulated with minocycline treatment,
and microglia frequently interact with and ensheath nonapop-
totic RGCs. Because RGC density in microglia depleted retinas
remains increased at birth, this suggests that these RGCs are via-
ble and normally eliminated by phagocytosis.
To date, the molecular mechanisms driving phagoptosis in
vivo are largely unknown. However, there is evidence that Mertk
and Mfge8 (Neher et al., 2013) are involved in engulfment of
stressed neurons following ischemia. In a model of ischemic
stroke, targeted inhibition of complement or KO of C3 limits
microglial contact and engulfment of stressed, noncleaved
caspase 3 neurons (Alawieh et al., 2018). Here, we find that
complement proteins are an important signal for RGC removal
by microglia. The complement system has been implicated in
development and disease with a primary focus on the ability of
complement to tag synapses for pruning (Stevens et al., 2007;
Schafer et al., 2012; Stephan et al., 2012; Zabel and Kirsch, 2013;
Hong et al., 2016; Coulthard et al., 2018; Hawksworth et al.,
2018). Complement is important for RGC-microglia interactions
during postnatal periods by marking RGC synapses in the LGN
for microglial engulfment (Schafer et al., 2012). We show that
complement signaling viaCR3 is required for normal elimination
of RGCs embryonically because an excess of RGCs was present at
P0 in the CR3 KO retina. It is likely other phagocytosis pathways
also contribute because we see less of an increase in RGC density
in CR3 KO retinas than is observed following microglial deple-
tion. These findings are consistentwith previouswork, where loss
of complement receptor signaling did not completely abolish
phagocytosis but reduced engulfment by 50% (Schafer et al.,
2012). One interesting candidate that may participate in RGC
elimination is LRP because we observed a significant downregu-
lation of its expression with minocycline treatment and LRP can
recognize C1q to stimulate phagocytosis (Brown and Neher,
2014). These findings represent some of the first evidence that
complement signaling can stimulate engulfment of entire neu-
rons in vivo. This has major ramifications not only during devel-
opment but also in pathological states.
Complement is upregulated early and implicated in driving
pathology in various contexts of injury and neurodegeneration
(Bonifati and Kishore, 2007; Zabel and Kirsch, 2013), including
glaucoma, which is the progressive decline and loss of RGCs
(Soto and Howell, 2014; Williams et al., 2017). During glaucoma
progression, complementproteins, suchasC1q,become localized to
RGCsynapses andcell bodies (Stevenset al., 2007).Therefore, it is an
intriguing possibility that the developmental microglia-RGC inter-
actions found here may reemerge in glaucoma.
We found that microglia were regulating RGC number em-
bryonically, with no apparent effect on cones or amacrine cells,
although effects on other cell types cannot be ruled out. Why a
subset of seemingly viable RGCs would be eliminated during
peak RGC genesis is unknown. Because RGC density is tightly
regulated (Wang et al., 2005) and various “don’t eat me” signals
limit aberrant phagocytosis (Elward and Gasque, 2003), it is un-
likely that microglia target RGCs stochastically. An alternative
hypothesis is that microglia target specific RGCs that may be less
fit for their environment. Many factors can influence whether a
newborn neuron will live or die during development, including
sufficient neurotrophic support, proper migration, correct tim-
ing, cell–cell interactions, successful axon guidance and innerva-
tion, and sufficient neuronal activity (Yamaguchi and Miura,
2015). Cell competition can also drive elimination of viable, but
less fit, cells during development (Gogna et al., 2015). A few
reports have illustrated the ability of microglia to “sense” and
eliminate neurons displaying cellular dysfunction and stress
(Brown andNeher, 2012, 2014; Zhao et al., 2015). Therefore, it is
possible that microglia eliminate stressed RGCs before they be-
come a liability or less fit RGCs competing for limited space and
resources. Our RGC labeling analysis with BrdU suggests that
RGCs are primarily being targeted at least 24 h after birth. While
this provides clues as to what could be driving their elimination,
various possibilities remain. RGC axons reach the optic nerve
24–48 h after birth (Farah and Easter, 2005), suggesting that
axon guidance mishaps could drive RGC elimination. Because
both minocycline treatment and genetic depletion of microglia
are systemic, it is possible that microglia may have important
roles at other RGC compartments, including RGC targets in the
brain, such as the superior colliculus or lateral geniculate nucleus.
Interestingly, complement components are important for the
proper migration of both neural crest cells and cortical neurons
(Coulthard et al., 2018). Therefore, it is also plausible that tar-
geted RGCs have improperly migrated. Because we identify C1q-
positive RGCs along the edge of the DCL where migrating RGCs
arrive, and we observe many microglia-RGC contact events, it is
intriguing to speculate that there is a checkpoint for newborn
RGCs. If true, this process may be another level of refinement
important for CNS development and function.
Currently, it is unclear whether the addition of these normally
eliminated RGCs has any long-term effects. By P6, we find a
slight, but insignificant, increase in Brn3 density in minocycline-
treated retinas (data not shown), suggesting that Brn3 density
normalizes and excess neurons may be eliminated during post-
natal apoptosis-mediated refinement (Farah, 2006).
While proper CNS development necessitates appropriate
production of cell types, the successful elimination of a fixed
proportion is essential for homeostasis andCNS refinement (Op-
penheim, 1991). Here, we provide evidence for a novel mecha-
nism of neuron elimination in the developing retina, whereby
microglia directly limit seemingly viable RGCs by phagocytosis.
We find this is partially dependent on complement signaling,
which exposes an ancillary role for this ancient signaling system.
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In addition, we uncover an avenue of microglia-neuron crosstalk
that could havemajor implications during CNS development but
also in complex contexts of injury and disease.
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